Market Size of Europe Hemodynamic Monitoring Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 5.00 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Europe Hemodynamic Monitoring Market Analysis
The European market for hemodynamic monitoring is expected to register a CAGR of around 5.0% over the forecast period. Factors that are augmenting the growth of the market in the European region are increasing critically ill geriatric population, the rise in the prevalence of cardiac disorders and diabetes, and increasing demand for home-based and non-invasive monitoring systems.
In Europe, the Ageing Report is published every three years by the Ageing Working Group of the Economic Policy Committee (EPC) and the European Commission’s Directorate-General for Economic and Financial Affairs (DG ECFIN), based on a mandate by the Council. As per the latest report by EPC (2018), the cost of ageing in the region is believed to grow by 1.7% to 26.7% of the GDP, till 2070. This long-term analysis was done to understand the negative impact of ageing in the European region. As the ageing population is increasing, there is a rising demand for monitoring tools, which is accelerating the growth of the hemodynamic monitoring market.
Certain factors, such as technological advances in the healthcare industry, along with its rapid adoption, are also fuelling the market.
Europe Hemodynamic Monitoring Industry Segmentation
Critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, which are also known as hemodynamic systems. The main function of these systems is to monitor cardiac activity. The hemodynamic systems give information about blood pressure, blood volume, and fluid balance.
This report contains a detailed analysis of the types of systems, application, and products that are available in the hemodynamic monitoring market.
| By Type of Systems | |
| Minimally-invasive Monitoring Systems | |
| Invasive Monitoring Systems | |
| Non-invasive Monitoring Systems |
| By Application | |
| Laboratory-based Monitoring Systems | |
| Home-based Monitoring Systems | |
| Hospital-based Monitoring Systems |
| By Type of Product | |
| Pressure Monitors | |
| Catheters | |
| Connecting Tubes | |
| Guidewires | |
| IV Fluid | |
| Transducers |
| Geography | ||||||||
|
Europe Hemodynamic Monitoring Market Size Summary
The European hemodynamic monitoring market is poised for steady growth, driven by an increasing critically ill geriatric population and a rising prevalence of cardiac disorders and diabetes. The demand for home-based and non-invasive monitoring systems is also contributing to market expansion. The ageing population in Europe, as highlighted by the Ageing Report, is creating a significant need for monitoring tools, thereby accelerating market growth. Technological advancements in healthcare, along with their rapid adoption, are further fueling the market. Hospital-based monitoring systems are expected to dominate the market, as they play a crucial role in managing multiple blood parameters, particularly in intensive care and emergency settings. Continuous hemodynamic monitoring is essential for optimizing diagnosis and minimizing complications, especially in anemic patients who are at higher risk for in-hospital complications.
The market landscape is moderately competitive, with major players like Edward Lifesciences, Getinge Group, Koninklijke Philips NV, ICU Medical, and Lidco Group leading the charge. These companies, along with a few smaller players, hold a significant share of the market. The ongoing growth of the healthcare industry and continuous technological advancements are likely to attract new entrants, further intensifying competition. The importance of hemodynamic monitors in hospitals, coupled with the increasing demand for improved care provision, suggests a positive outlook for the market in the coming years.
Europe Hemodynamic Monitoring Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Type of Systems
-
2.1.1 Minimally-invasive Monitoring Systems
-
2.1.2 Invasive Monitoring Systems
-
2.1.3 Non-invasive Monitoring Systems
-
-
2.2 By Application
-
2.2.1 Laboratory-based Monitoring Systems
-
2.2.2 Home-based Monitoring Systems
-
2.2.3 Hospital-based Monitoring Systems
-
-
2.3 By Type of Product
-
2.3.1 Pressure Monitors
-
2.3.2 Catheters
-
2.3.3 Connecting Tubes
-
2.3.4 Guidewires
-
2.3.5 IV Fluid
-
2.3.6 Transducers
-
-
2.4 Geography
-
2.4.1 Europe
-
2.4.1.1 Germany
-
2.4.1.2 UK
-
2.4.1.3 France
-
2.4.1.4 Italy
-
2.4.1.5 Spain
-
2.4.1.6 Rest of Europe
-
-
-
Europe Hemodynamic Monitoring Market Size FAQs
What is the current Europe Hemodynamic Monitoring Market size?
The Europe Hemodynamic Monitoring Market is projected to register a CAGR of 5% during the forecast period (2024-2029)
Who are the key players in Europe Hemodynamic Monitoring Market?
Edwards Lifesciences, Koninklijke Philips NV, Lidco Group, ICU Medical Inc. and Getinge AB are the major companies operating in the Europe Hemodynamic Monitoring Market.
